SUBSCRIBE
SUBSCRIBE
News   Business

Rainbow BioSciences, LLC Negotiates Funding Terms with n3D

February 6, 2012 | 
1 min read

NOKOMIS, Fla.--(BUSINESS WIRE)--Rainbow Biosciences, the biotech division of Rainbow Coral Corp. (OTCBB:RBCC), announced today that it’s on the cusp of a major breakthrough in its business relationship with n3D Biosciences.

Alliances
MORE ON THIS TOPIC
Signage at Pfizer's world headquarters in New York City
Manufacturing
Pfizer Prepared to Reshore Manufacturing if Trump Makes Good on Tariff Threats
March 4, 2025
 · 
2 min read
 · 
Tristan Manalac
Podcast
A Conversation With Kevin Marks, CEO of Delphia
March 4, 2025
 · 
1 min read
 · 
Annalee Armstrong
Contemporary art collage of hand holding a dart aiming at the target. Business targeting, aiming, focus concept. Modern design. Copy space.
NextGen
Delphia Eyes New Precision Medicine Approach: Activation Lethality
March 4, 2025
 · 
2 min read
 · 
Annalee Armstrong
Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant
Layoff Tracker
CRISPR, Cytiva Laying Off Employees
March 3, 2025
 · 
139 min read
 · 
BioSpace Editorial Staff